Pyruvate Dehydrogenase and Cellular Metabolism in Calcineurin Inhibitor–Induced Kidney Fibrosis

Key Points Calcineurin inhibition deactivated pyruvate dehydrogenase and induced proximal tubule cell metabolic dysfunction. The impaired mitochondrial metabolism caused a proinflammatory, profibrotic phenotype, thereby contributing to kidney fibrosis. Metabolic dysfunction in tubular cells is a potential target for intervention in chronic calcineurin inhibitor nephrotoxicity. Background Calcineurin inhibitors (CNIs) are indispensable immunosuppressants for transplant recipients and patients with autoimmune diseases, but chronic use causes nephrotoxicity, including kidney fibrosis. Why inhibiting calcineurin, a serine/threonine phosphatase, causes kidney fibrosis has not been fully elucidated. Methods To characterize the phenotypic changes in the early stages of chronic CNI nephrotoxicity at single-cell resolution, kidney tissues from a chronic CNI nephrotoxicity mouse model and its control were subjected to single-nucleus RNA sequencing. ICR mice were fed a low-sodium diet and received 30 mg/kg per day cyclosporin A, 3 mg/kg per day tacrolimus, or vehicle for up to 4 weeks. Primary human renal proximal tubule epithelial cells were cultured with cyclosporin A, tacrolimus, or vehicle. Results Single-nucleus RNA sequencing of the kidney from a chronic CNI nephrotoxicity mouse model found a higher proportion of injured proximal tubule cells, which exhibited altered expression of genes associated with oxidative phosphorylation, cellular senescence, and fibrosis. Analyses of publicly available transcriptomes of human kidneys confirmed that some of these manifestations were observed in human allograft kidneys under certain conditions. In cultured primary human renal proximal tubule epithelial cells, CNIs caused phosphorylation (deactivation) of pyruvate dehydrogenase, impaired mitochondrial metabolism, and senescence-associated phenotypes, all of which were ameliorated by pyruvate dehydrogenase activation. Finally, administration of dichloroacetic acid, a known activator of pyruvate dehydrogenase, in the chronic CNI nephrotoxicity mouse model mitigated kidney fibrosis, increased the expression of genes that encode the electron transportation chain components, and decreased the expression of genes associated with proximal tubule injury, cellular senescence, and fibrosis. Conclusions Calcineurin inhibition deactivated pyruvate dehydrogenase and induced proximal tubule cell metabolic dysfunction, causing profibrotic phenotype. Metabolic dysfunction in proximal tubule cells may be a signature of chronic CNI nephrotoxicity, appearing at an early stage.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-08-29
DOI
https://doi.org/10.1681/asn.0000000855
Citations
2
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
3.97
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pyruvate Dehydrogenase and Cellular Metabolism in Calcineurin Inhibitor–Induced Kidney Fibrosis

Yasuhiro Oda, Fumie Hamano, Masaomi Nangaku, Jeffrey B. Kopp et al.
2 citations
Journal of the American Society of Nephrology
Renal Transplantation Outcomes and Treatments
3.97
article

Pyruvate Dehydrogenase and Cellular Metabolism in Calcineurin Inhibitor–Induced Kidney Fibrosis

Yasuhiro Oda, Fumie Hamano, Masaomi Nangaku, Jeffrey B. Kopp, Teruhiko Yoshida, Hiroshi Nishi, Yoshihiro Kita
article en
2 citations

Abstract

Key Points Calcineurin inhibition deactivated pyruvate dehydrogenase and induced proximal tubule cell metabolic dysfunction. The impaired mitochondrial metabolism caused a proinflammatory, profibrotic phenotype, thereby contributing to kidney fibrosis. Metabolic dysfunction in tubular cells is a potential target for intervention in chronic calcineurin inhibitor nephrotoxicity. Background Calcineurin inhibitors (CNIs) are indispensable immunosuppressants for transplant recipients and patients with autoimmune diseases, but chronic use causes nephrotoxicity, including kidney fibrosis. Why inhibiting calcineurin, a serine/threonine phosphatase, causes kidney fibrosis has not been fully elucidated. Methods To characterize the phenotypic changes in the early stages of chronic CNI nephrotoxicity at single-cell resolution, kidney tissues from a chronic CNI nephrotoxicity mouse model and its control were subjected to single-nucleus RNA sequencing. ICR mice were fed a low-sodium diet and received 30 mg/kg per day cyclosporin A, 3 mg/kg per day tacrolimus, or vehicle for up to 4 weeks. Primary human renal proximal tubule epithelial cells were cultured with cyclosporin A, tacrolimus, or vehicle. Results Single-nucleus RNA sequencing of the kidney from a chronic CNI nephrotoxicity mouse model found a higher proportion of injured proximal tubule cells, which exhibited altered expression of genes associated with oxidative phosphorylation, cellular senescence, and fibrosis. Analyses of publicly available transcriptomes of human kidneys confirmed that some of these manifestations were observed in human allograft kidneys under certain conditions. In cultured primary human renal proximal tubule epithelial cells, CNIs caused phosphorylation (deactivation) of pyruvate dehydrogenase, impaired mitochondrial metabolism, and senescence-associated phenotypes, all of which were ameliorated by pyruvate dehydrogenase activation. Finally, administration of dichloroacetic acid, a known activator of pyruvate dehydrogenase, in the chronic CNI nephrotoxicity mouse model mitigated kidney fibrosis, increased the expression of genes that encode the electron transportation chain components, and decreased the expression of genes associated with proximal tubule injury, cellular senescence, and fibrosis. Conclusions Calcineurin inhibition deactivated pyruvate dehydrogenase and induced proximal tubule cell metabolic dysfunction, causing profibrotic phenotype. Metabolic dysfunction in proximal tubule cells may be a signature of chronic CNI nephrotoxicity, appearing at an early stage.

Journal of the American Society of NephrologyVol. 37(3)
National Institutes of Health (US), National Institute of Diabetes and Digestive and Kidney Diseases (US), The University of Tokyo (JP)
Openalex Percentile: Top 6%
Renal Transplantation Outcomes and Treatments
3.97
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.